Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Cost of Revenue (2016 - 2025)

Merit Medical Systems' Cost of Revenue history spans 16 years, with the latest figure at $198.6 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 9.01% year-over-year to $198.6 million; the TTM value through Dec 2025 reached $777.6 million, up 9.04%, while the annual FY2025 figure was $777.6 million, 9.04% up from the prior year.
  • Cost of Revenue for Q4 2025 was $198.6 million at Merit Medical Systems, roughly flat from $197.7 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $198.6 million in Q4 2025 and bottomed at $137.0 million in Q1 2021.
  • The 5-year median for Cost of Revenue is $169.5 million (2023), against an average of $169.3 million.
  • The largest YoY upside for Cost of Revenue was 16.42% in 2021 against a maximum downside of 1.95% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at $149.7 million in 2021, then grew by 6.13% to $158.9 million in 2022, then rose by 9.52% to $174.0 million in 2023, then grew by 4.71% to $182.2 million in 2024, then grew by 9.01% to $198.6 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Cost of Revenue are $198.6 million (Q4 2025), $197.7 million (Q3 2025), and $198.0 million (Q2 2025).